Research Article
Prognostic Value of Hepatocyte Growth Factor, Syndecan-1, and Osteopontin in Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance
Table 1
Characteristics of the analyzed group.
| | MM | MGUS |
| | N | 156 | 78 | | Age median (years) | 65 (range 32–86) | 62 (range 31–86) | | M/F ratio | 1,08 : 1 | 0,56 : 1 | | MIg type | | | | IgG | 98 (63%) | 60 (77%) | | IgA | 43 (27%) | 14 (18%) | | Bence-Jones | 14 (9%) | 3 (4%) | | IgD | 1 (1%) | — | | Biclonal | — | 1 | | ratio | 2,55 | 1,7 |
| | MM stage | | | | ISS 1 | 98 (63%) | — | | ISS 2 | 39 (25%) | — | | ISS 3 | 19 (12%) | — | | DS I | 15 (10%) | — | | DS II | 71 (46%) | — | | DS III | 70 (44%) | — | | Substage A | 149 (96%) | — | | Substage B | 7 (4%) | — |
|
|
